1. Home
  2. AWX vs NLSP Comparison

AWX vs NLSP Comparison

Compare AWX & NLSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AWX
  • NLSP
  • Stock Information
  • Founded
  • AWX 1998
  • NLSP 2015
  • Country
  • AWX United States
  • NLSP Switzerland
  • Employees
  • AWX N/A
  • NLSP N/A
  • Industry
  • AWX Environmental Services
  • NLSP Biotechnology: Pharmaceutical Preparations
  • Sector
  • AWX Utilities
  • NLSP Health Care
  • Exchange
  • AWX Nasdaq
  • NLSP Nasdaq
  • Market Cap
  • AWX 9.7M
  • NLSP 12.4M
  • IPO Year
  • AWX 1998
  • NLSP 2021
  • Fundamental
  • Price
  • AWX $2.51
  • NLSP $2.10
  • Analyst Decision
  • AWX
  • NLSP
  • Analyst Count
  • AWX 0
  • NLSP 0
  • Target Price
  • AWX N/A
  • NLSP N/A
  • AVG Volume (30 Days)
  • AWX 13.8K
  • NLSP 275.3K
  • Earning Date
  • AWX 08-07-2025
  • NLSP 07-22-2025
  • Dividend Yield
  • AWX N/A
  • NLSP N/A
  • EPS Growth
  • AWX N/A
  • NLSP N/A
  • EPS
  • AWX 0.20
  • NLSP N/A
  • Revenue
  • AWX $81,005,000.00
  • NLSP N/A
  • Revenue This Year
  • AWX N/A
  • NLSP N/A
  • Revenue Next Year
  • AWX N/A
  • NLSP N/A
  • P/E Ratio
  • AWX $12.12
  • NLSP N/A
  • Revenue Growth
  • AWX N/A
  • NLSP N/A
  • 52 Week Low
  • AWX $2.10
  • NLSP $1.30
  • 52 Week High
  • AWX $3.99
  • NLSP $15.59
  • Technical
  • Relative Strength Index (RSI)
  • AWX 58.31
  • NLSP 46.61
  • Support Level
  • AWX $2.39
  • NLSP $2.20
  • Resistance Level
  • AWX $2.47
  • NLSP $3.08
  • Average True Range (ATR)
  • AWX 0.05
  • NLSP 0.25
  • MACD
  • AWX 0.01
  • NLSP -0.06
  • Stochastic Oscillator
  • AWX 100.00
  • NLSP 8.40

About AWX Avalon Holdings Corporation

Avalon Holdings Corp is a waste management company. The company provides waste management services to industrial, commercial, municipal, and governmental customers in selected northeastern and midwestern U.S. markets. The company has two operating segments. The Waste management services segment which is the key revenue driver, includes waste disposal services, captive landfill operations, and saltwater injection well operations. Its Golf and related operations segment includes management of golf courses and related clubhouses, a hotel, fitness centers, tennis courts, salon and spa services, dining, banquet, and conference facilities.

About NLSP NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd a clinical-stage biopharmaceutical company focused on the discovery and development of inventive therapies for patients with rare and complex CNS disorders with unmet medical needs. Its compound, mazindol, a triple monoamine reuptake inhibitor and partial orexin receptor 2 agonist, in a proprietary ER formulation, is being developed for the treatment of narcolepsy, IH (follow-on indication), and potentially ADHD (back-up indication). Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.

Share on Social Networks: